English Session
- EngJapanese / English Session
Program
[As of Feb. 16, 2026]
Wednesday, April 22
- Symposium 1 : New Perspectives on Pathophysiological Mechanisms and Clinical Complexity in Connective Tissue DiseasesEng
- Symposium 4 : State-of-the-art; the latest clinical perspectives in systemic autoimmune diseases
- Symposium 7 : Recent advances in translational and basic research of autoimmune diseases
- Luncheon Seminar 8 : Interstitial Lung Disease in connective tissue disease: from diagnosis to management What is new (WIN)
- Evening Seminar 5 : The Importance of Interleukin-6 for autoimmune diseases
Thursday, April 23
- Special Symposium 2 : APLAR Session
- Special Symposium 3 : EULAR Session
- TREG Session : Conference analysis of ACR 2025 and EULAR 2025
- Symposium 12 (J-STAR Session) : Comprehensive approach to Difficult to treat SLE (J-STAR Session)
- Educational Lecture 12 : Research using medical claims and other large-scale healthcare databasesEng
- Evening Seminar 10 : Optimizing Early Diagnosis and Treatment Strategies in Rheumatoid Arthritis
Friday, April 24
- Special Symposium 4 : ACR Session
- Symposium 16 : Updates and Future Perspectives on Guidelines for Rheumatic DiseasesEng
- Symposium 17 : Frontiers in the Pathogenesis of Systemic Lupus Erythematosus
- Symposium 19 : Deciphering the Pathogenesis of Rheumatoid Arthritis through Single-Cell Analysis
- Luncheon Seminar 24 : Evolving Concepts in the Myopathology of Immune Myopathies
- Luncheon Seminar 27 : Is hypophosphatasia hiding among our patients in rheumatology clinics?
- Luncheon Seminar 33 : Achieving the Best Outcomes in RA: The Role of JAK Inhibition in 2026 and Beyond
Special Symposium
Special Symposium 2
APLAR Session
Thursday, April 23 8:55 - 10:55 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Jose Paulo LorenzoMakati Medical Center and the University of the Philippines, Philippines
- Yukinori OkadaThe University of Tokyo
- Jose Paulo LorenzoMakati Medical Center and the University of the Philippines, Philippines
- Lai-Shan TamThe Chinese University of Hong Kong, Hong Kong
- Shin-Seok LeeChonnam National University Medical School & Hospital, Republic of Korea
- Michihito KonoDepartment of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University
SS2-1The APLAR GOUT Registry: Observations, Insights, and Applications
SS2-2The APLAR SpA Registry: Achievements, Impact, and Future Prospects
SS2-3The Lupus Registry: What We have Learned and Evolving Treatment Strategies
SS2-4SLE guideline
Special Symposium 3
EULAR Session
Thursday, April 23 15:20 - 17:20 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Daniel AletahaDepartment of Medicine Ⅲ, Medical University of Vienna, Austria
- Kunihiro YamaokaKitasato University
- Daniel AletahaDepartment of Medicine Ⅲ, Medical University of Vienna, Austria
- Xenofon Baraliakos Rheumazentrum Ruhrgebiet Herne, Ruhr Universität Bochum, Germany
- Christopher J. EdwardsNIHR Southampton Clinical Research Facility, University Hospital Southampton, Southampton, UK
SS3-1
SS3-2Gender differences in axial Spondyloarthritis
SS3-3Treatment approaches for Rheumatoid Arthritis
Special Symposium 4
ACR Session
Friday, April 24 8:45 - 10:45 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Hideto KamedaDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University
- Takeshi MiyamotoDepartment of Orthopedic Surgery, Faculty of Life Sciences, Kumamoto University
- Bryant R. EnglandUniversity of Nebraska Medical Center, USA
- Kristine A. KuhnUniversity of Colorado Anschutz
SS4-1Lung Disease in Rheumatoid Arthritis
SS4-2Mucosal Immunopathology of Arthritis
TREG Session
TREG Session
Conference analysis of ACR 2025 and EULAR 2025
Thursday, April 23 8:55 - 10:55 Room 1 (Concert Hall, 2F, Fukuoka Sunpalace)
- Chairs
- Yoshiya TanakaDistinguished Professor, Department of Molecular Targeted Therapaeutics, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
- Roy M. FleischmannUniversity of Texas Southwestern Medical Center, USA
- Allan GibofskyHospital for Special Surgery-Weill Cornell Medicine, USA
- Arthur KavanaughUniversity of California, San Diego School of Medicine, USA
- Philip MeaseProvidence Swedish Medical Center, USA
TS-1New Molecules in Development for Rheumatic Disease
TS-2Systemic Lupus Erythematosus/Autoimmune Diseases
TS-3Progress in the Therapeutic Approach to Rheumatoid Arthritis (RA) and VasculitisTREG: conference analysis ACR 2025 and EULAR 2025
TS-4Spondyloarthritis Review: ACR and EULAR 2025
Symposium
Symposium 1Eng
New Perspectives on Pathophysiological Mechanisms and Clinical Complexity in Connective Tissue Diseases
Wednesday, April 22 9:50 - 12:20 Room 1 (Concert Hall, 2F, Fukuoka Sunpalace)
- Chairs
- Tatsuya AtsumiDepartment of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University
- Yoshiya TanakaDistinguished Professor, Department of Molecular Targeted Therapaeutics, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
- Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan
- Shinsuke YasudaGraduate School of Medical and Dental Sciences, Institute of Science Tokyo Department of Rheumatology
- Masayuki NishideDepartment of Respiratory Medicine and Clinical Immunology The University of Osaka Graduate School of Medicine
- Satoshi KuboThe First department of internal medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
- David A. IsenbergUniversity College London UK
S1-1Mechanisms Underlying Refractory Disease in Systemic Lupus Erythematosus
S1-2Idiopathic inflammatory myopathies
S1-3Understanding the Pathogenesis of ANCA-Associated Vasculitis through Single-Cell and Spatial Omics Analysis
S1-4Pathogenesis and recent findings in Mixed Connective Tissue Disease(MCTD)
S1-5Biologic therapies for SLE - What's In, What's Out, What's Coming?Eng
Symposium 4
State-of-the-art; the latest clinical perspectives in systemic autoimmune diseases
Wednesday, April 22 9:50 - 12:20 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine
- Tahseen MozaffarDepartment of Neurology and Pathology, University of California, Irvine, USA
- Iain B. McInnesUniversity of Glasgow, Glasgow, United Kingdom
- Michihito KonoDepartment of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University
- Anna-Maria Hoffmann-VoldOslo University Hospital, Norway
- Tahseen MozaffarDepartment of Neurology and Pathology, University of California, Irvine, USA
- Hiroaki NiiroDepartment of Medical Education, Graduate School of Medical Sciences, Kyushu University
S4-1Rheumatoid arthritis: advances in therapeutic discovery and clinical strategic approaches
S4-2State-of-the-art of the systemic lupus erythematosus
S4-3Interstitial lung disease related with connective tissue diseases
S4-4Idiopathic inflammatory myopathies
S4-5Systemic vasculitis
Symposium 7
Recent advances in translational and basic research of autoimmune diseases
Wednesday, April 22 14:35 - 17:05 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Sachiko MiyakeJuntendo University
- Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo
- Francesco CicciaUniversity della Campania L. Vanvitelli, Italy
- Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo
- Hiroyuki YoshitomiDepartment of Immunology, Graduate School of Medicine, Kyoto University
- Felice RivelleseQueen Mary University of London, United Kingdom
- Ricardo Grieshaber-bouyerFriedrich-Alexander-Universität Erlangen-Nürnberg
S7-1Resident memory T cells in Sjogren's disease
S7-2Identification of immunological pathways associated with the clinical phenotypes of autoimmune diseases
S7-3Peripheral helper T cells go beyond B-cell help in rheumatoid arthritis
S7-4Synovial biopsies in the personalised treatment of arthritis
S7-5Precision cell depletion as the next therapeutic frontier in autoimmune diseases
Symposium 12 (J-STAR Session)
Comprehensive approach to Difficult to treat SLE (J-STAR Session)
Thursday, April 23 14:35 - 17:05 Room 7 (409+410, 4F, Fukuoka International Congress Center)
- Chairs
- Sho SendoKobe University
- Yurie KandaUniversity of Occupational and Environmental Health
- Commentator
- David A. IsenbergUniversity College London UK
- Wataru FujiiDepartment of Rheumatology, Dokkyo Medical University
- Hsin-Hua ChenTaichung Veterans General Hospital, Taiwan
- Carlo TurDepartment of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Germany
- Takehiro NakaiImmuno-Rheumatology Center, St. Luke's International Hospital
- Keisuke ImabayashiDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
- Dai DaiShanghai Institute of Rheumatology, Renji Hospital, Shanghai JiaoTong University School of Medicine, China (People's Republic of China)
S12-1A case of difficult-to-treat systemic lupus erythematosus
S12-2CAR-T Cell Therapy in SLE: Mechanisms, Clinical Efficacy, and Future Directions
S12-3B-cell depletion and lymphoid follicle disruption following different B-cell depleting agents
S12-4
S12-5Continuous Self-Antigen-Driven BCR Signaling Governs the Generation and Maintenance of Age-Associated B Cells
S12-6IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus
Symposium 16Eng
Updates and Future Perspectives on Guidelines for Rheumatic Diseases
Friday, April 24 14:30 - 17:00 Room 1 (Concert Hall, 2F, Fukuoka Sunpalace)
- Chairs
- Hiroaki DobashiKagawa University
- Yutaka KawahitoKyoto Prefectural University of Medicine
- Tatsuya AtsumiDepartment of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University
- Felice RivelleseQueen Mary University of London, United Kingdom
- Shintaro HirataDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital
- Hiroaki DobashiKagawa University
- Anna-Maria Hoffmann-VoldOslo University Hospital, Norway
- Hidekata YasuokaDivision of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine
- Hideki NakamuraDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine
S16-1Systemic Lupus Erythematosus Clinical Practice Guidelines 2026
S16-2RAEng
S16-3Recent advances and future perspectives in clinical practice guidelines for rheumatoid arthritisEng
S16-4
S16-5SScEng
S16-6Systemic sclerosisEng
S16-7Revisions and issues of the guideline for Sjögren disease
Symposium 17
Frontiers in the Pathogenesis of Systemic Lupus Erythematosus
Friday, April 24 14:30 - 17:00 Room 5 (Main Hall, 3F, Fukuoka International Congress Center)
- Chairs
- Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo
- Sachiko MiyakeJuntendo University
- Shingo NakayamadaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
- Tomohisa OkamuraDepartment of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo
- George TsokosBeth Israel Deaconess Medical Center, Harvard Medical School, USA
- Simone CaielliDepartment of Pediatrics, Weill Cornell Medicine, USA
- Ryosuke HiwaDepartment of Rheumatology and Clinical Immunology, Kyoto University Hospital
S17-1T Follicular Helper Cell in Systemic Lupus Erythematosus
S17-2The Role of Age-Associated ThA Cells in the Pathogenesis of Systemic Lupus Erythematosus
S17-3T Cell Metabolism in Lupus
S17-4Single cell RNA profiling of blood CD4+ T cells identifies distinct helper and dysfunctional regulatory clusters in children with SLE
S17-5The Role of the Nuclear Receptor NR4A Family in SLE
Symposium 19
Deciphering the Pathogenesis of Rheumatoid Arthritis through Single-Cell Analysis
Friday, April 24 14:30 - 17:00 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Hiroshi TakayanagiThe University of Tokyo
- Soumya RaychaudhuriHarvard Medical School;Brigham and Women's Hospital; Broad Institute, USA
- Soumya RaychaudhuriHarvard Medical School;Brigham and Women's Hospital; Broad Institute, USA
- Kevin WeiBrigham and Women's Hospital at Harvard Medical School, USA
- Haruka TsuchiyaDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo
- Kazuyoshi IshigakiDepartment of Microbiology and Immunology, Keio University School of Medicine
- Mariola Kurowska-StolarskaUniversity of Glasgow, UK
S19-1Using Human Genetics and Genome Editing to Define Autoimmune Mechanisms for Rheumatoid Arthritis
S19-2Spatial transcriptomic analysis of RA synovia
S19-3Journey ahead - aging well with rheumatoid arthritis
S19-4Multi-modal single-cell dissection of rheumatoid arthritis polygenic risk
S19-5
Educational Lecture
Educational Lecture 12Eng
Research using medical claims and other large-scale healthcare databases
Thursday, April 23 9:55 - 10:55 Room 9 (413+414, 4F, Fukuoka International Congress Center)
- Chairs
- Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan
- Nobuyuki YajimaShowa Medical University Division of Rheumatology, Department of Medicine
- Yoon-Kyoung SungHanyang University, Korea
EL12-1Research using medical claims and other large-scale healthcare databases
EL12-2Research Using Healthcare Electronic Big DataEng
Lunchen Seminar
Luncheon Seminar 8
Interstitial Lung Disease in connective tissue disease: from diagnosis to management
What is new (WIN)
Wednesday, April 22 12:35 - 13:35 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Hidekata YasuokaDivision of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine
- Anna-Maria Hoffmann-VoldDepartment of Rheumatology, Oslo University Hospital, Oslo, Norway
- Sponsored
- Nippon Boehringer Ingelheim Co., Ltd. Medicine Division
LS8Interstitial Lung Disease in connective tissue disease: from diagnosis to management
What is new (WIN)
What is new (WIN)
Luncheon Seminar 24
Evolving Concepts in the Myopathology of Immune Myopathies
Friday, April 24 12:10 - 13:10 Room 1 (Concert Hall, 2F, Fukuoka Sunpalace)
- Chairs
- Ichizo NishinoNational Center of Neurology and Psychiatry, Tokyo, Japan
- Tahseen MozaffarUniversity of California, Irvine, California, USA
- Sponsored
- Japan Blood Products Organization
LS24Evolving Concepts in the Myopathology of Immune Myopathies
Luncheon Seminar 27
Is hypophosphatasia hiding among our patients in rheumatology clinics?
Friday, April 24 12:10 - 13:10 Room 4 (203+204, 2F, Fukuoka International Congress Center)
- Chairs
- Masaru KatoUniversity of Toyama Faculty of Medicine, The First Department of Internal Medicine
- Katie MossSt George’s University Hospitals, NHS Foundation Trust, London, UK
- Sponsored
- Alexion Pharma GK
LS27Is hypophosphatasia hiding among our patients in rheumatology clinics?
Luncheon Seminar 33
Achieving the Best Outcomes in RA: The Role of JAK Inhibition in 2026 and Beyond
Friday, April 24 12:10 - 13:10 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine
- James GallowayCentre for Rheumatic Disease, King's College London, London, United Kingdom
- Sponsored
- Gilead Sciences K.K./Eisai Co., Ltd.
LS33Achieving the Best Outcomes in RA: The Role of JAK Inhibition in 2026 and Beyond
Evening Seminar
Evening Seminar 5
The Importance of Interleukin-6 for autoimmune diseases
Wednesday, April 22 17:20 - 18:50 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Tsutomu TakeuchiSaitama Medical University / Keio University School of Medicine
- Kunihiro YamaokaDepartment of Rheumatology, Kitasato University School of Medicine
- Iain B. McInnesCollege of Medical, Veterinary & Life Sciences (MVLS), University of Glasgow, Glasgow, UK
- Masataka KuwanaDepartment of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan
- Sponsored
- CHUGAI PHARMACEUTICAL CO., LTD.
ES5-1The importance of IL-6 for autoimmune diseases
ES5-2Initial Treatment Strategies for Rheumatoid Arthritis: Different approach depending on age
Evening Seminar 10
Optimizing Early Diagnosis and Treatment Strategies in Rheumatoid Arthritis
Thursday, April 23 17:45 - 19:15 Room 10 (501, 5F, Fukuoka International Congress Center)
- Chairs
- Takao KoikeHokkaido Medical Center for Rheumatic Diseases
- Kei IkedaDepartment of Rheumatology, Dokkyo Medical University
- Tadashi OkanoDepartment of Musculoskeletal Aging and Degenerative Disorders Control, Graduate School of Medicine, Osaka Metropolitan University
- Emilio FilippucciClinica Reumatologia - Università Politecnica delle Marche
- Sponsored
- Gilead Sciences K.K./Eisai Co.,Ltd.
ES10-1Diagnosis of Pre-RA and Early RA using musculoskeletal ultrasound
ES10-2Clinical Significance of Musculoskeletal Ultrasound in Rheumatoid Arthritis Treatment: Early Intervention and Treatment Response Assessment
ES10-3Ultrasound in RA: A European Perspective on Early Diagnosis and Treatment Monitoring